Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2010 Dicembre;52(4) > Panminerva Medica 2010 Dicembre;52(4):331-8

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

PANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

  IMAGING AND FOCAL THERAPY IN PROSTATE AND KIDNEY CANCER PART II: FOCUS ON KIDNEY


Panminerva Medica 2010 Dicembre;52(4):331-8

lingua: Inglese

Laparoscopic and percutaneous cryotherapy for renal neoplasms

Stroup S. P., Kopp R. P., Derweesh I. H.

Division of Urology/Department of Surgery, University of California San Diego, School of Medicine, La Jolla, California, USA


PDF  


Incidence of renal cell carcinoma is increasing. There has been a shift towards utilization of nephron sparing surgery when feasible. Minimally invasive ablative treatments such as laparoscopic and percutaneous renal cryoablation aim to treat renal tumors with the two goals of cancer eradication and reduced morbidity compared to excisional surgical approaches. In this article, we review the basis of cryobiology and examine the current role of renal cryoablation and analyze the current literature focusing on laparoscopic and percutaneous approaches and discuss future directions and refinements in cryosurgical technology. While renal cryoablation is associated with higher local retreatment rates compared to radical or partial nephrectomy, emerging reports of intermediate-term oncological outcomes suggest disease-specific survival approaching that of extirpative surgery. Further follow up is needed to elucidate the long-term oncologic outcomes of and effects on renal function by renal cryoablation.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

iderweesh@gmail.com